Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Change in Taxes (2020 - 2024)

Historic Change in Taxes for BioNexus Gene Lab (BGLC) over the last 5 years, with Q3 2024 value amounting to -$87057.0.

  • BioNexus Gene Lab's Change in Taxes fell 648247.8% to -$87057.0 in Q3 2024 from the same period last year, while for Sep 2024 it was -$53591.0, marking a year-over-year increase of 6795.7%. This contributed to the annual value of -$44648.0 for FY2023, which is 42199.62% down from last year.
  • Per BioNexus Gene Lab's latest filing, its Change in Taxes stood at -$87057.0 for Q3 2024, which was down 648247.8% from $57018.0 recorded in Q2 2024.
  • Over the past 5 years, BioNexus Gene Lab's Change in Taxes peaked at $107779.0 during Q4 2020, and registered a low of -$139343.0 during Q4 2022.
  • For the 5-year period, BioNexus Gene Lab's Change in Taxes averaged around $1417.9, with its median value being -$3540.0 (2023).
  • Per our database at Business Quant, BioNexus Gene Lab's Change in Taxes soared by 33928.12% in 2021 and then plummeted by 648247.8% in 2024.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Change in Taxes stood at $107779.0 in 2020, then crashed by 122.26% to -$23994.0 in 2021, then crashed by 480.74% to -$139343.0 in 2022, then skyrocketed by 87.98% to -$16744.0 in 2023, then tumbled by 419.93% to -$87057.0 in 2024.
  • Its last three reported values are -$87057.0 in Q3 2024, $57018.0 for Q2 2024, and -$6808.0 during Q1 2024.